4- (2-chloro-3-methylphenylamine) -3-thiophene-carboxylate, a highly active anti-inflammatory drug
Alpermann, H.G.; Ruschig, H.; Meixner, W.
Arzneimittel-Forschung 22(12): 2146-2147
1972
ISSN/ISBN: 0004-4172 PMID: 4679186 Document Number: 55096
Document emailed within 1 workday
Related Documents
Imamura, E.; Yamashita, H.; Fukuhara, T.; Sawa, H.; Nagashima, K.; Kuwabara, M.; Tokinobu, H. 2007: Case of highly active anti-retroviral therapy-induced immune reconstitution inflammatory syndrome in AIDS-related progressive multifocal leukoencephalopathy Rinsho Shinkeigaku 47(10): 650-656Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046
Gavrilov, V.; Steiner, M.; Shany, S. 2005: The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth Anticancer Research 25(5): 3425-3429
De Arcangelis, A. 1971: On the use in anti-rheumatic therapy of a new non-steroid anti-inflammatory agent: glucosamide of monohydrated (N-p-chloro-benzoyl-2-methyl-5-methoxy)-indol-3-acetic acid La Clinica Terapeutica 59(3): 229-239
Di Braccio, M.; Roma, G.; Grossi, G.; Ghia, M.; Mattioli, F. 1997: 1,8-Naphthyridines. III. N,N-dialkyl-5-chloro[1,2,4]-triazolo[4,3-a][1,8]naphthyridine-6-carboxa mides with anti-inflammatory activity Farmaco 52(1): 49-53
Villarroya, F.; Domingo, P.; Giralt, M. 2005: Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity Trends in Pharmacological Sciences 26(2): 88-93
Ceker, S.; Ogutcu, H.ıc.; Meral, S.; Agar, A.A.; Agar, G. 2019: Synthesis, anti-microbial and anti-mutagenic activities of some Schiff bases derivatives containing thiophene group Pakistan Journal of Pharmaceutical Sciences 32(6): 2679-2686
Wiesenberg-Boettcher, I.; Schweizer, A.; Green, J.R.; Mueller, K.; Maerki, F.; Pfeilschifter, J. 1989: The pharmacological profile of CGP 28238, a novel highly potent anti-inflammatory compound Drugs under Experimental and Clinical Research 15(11-12): 501-509
Tiwari, B.R.; Karki, S.; Ghimire, P.; Sharma, B.; Malla, S. 2013: Improvement in immunological parameters in patients receiving highly active anti-retroviral therapy in Nepal Japanese Journal of Infectious Diseases 66(3): 252-255
Miiro, G.; Todd, J.; Mpendo, J.; Watera, C.; Munderi, P.; Nakubulwa, S.; Kaddu, I.; Rutebarika, D.; Grosskurth, H. 2009: Reduced morbidity and mortality in the first year after initiating highly active anti-retroviral therapy (HAART) among Ugandan adults Tropical Medicine and International Health: Tm and Ih 14(5): 556-563
Bunton, R.W. 1983: Reintroduction of anti-inflammatory drug therapy after drug-associated gastrointestinal disturbances New Zealand Medical Journal 96(726): 144
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Bouhnik, A.-D.éb.; Préau, M.; Vincent, E.; Carrieri, M.P.; Gallais, H.é; Lepeu, G.ér.; Gastaut, J.-A.; Moatti, J.-P.; Spire, B. 2005: Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy Antiviral Therapy 10(1): 53-61
Galeazzi, M.; Marcolongo, R. 1993: A placebo-controlled study of the efficacy and tolerability of a nonsteroidal anti-inflammatory drug, DHEP plaster, in inflammatory peri- and extra-articular rheumatological diseases Drugs under Experimental and Clinical Research 19(3): 107-115
Iduoriyekemwen, N.J.; Sadoh, W.E.; Sadoh, A.E. 2013: Prevalence of renal disease in Nigerian children infected with the human immunodeficiency virus and on highly active anti-retroviral therapy Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 24(1): 172-177
Klimova, K.N.; Mineeva, N.V. 1986: The role of factors influencing the hemagglutination reaction in the preparation of highly active typing anti-erythrocyte sera and detection of alloantibodies Gematologiia i Transfuziologiia 31(12): 40-46
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Minzi, O.M.S.; Irunde, H.; Moshiro, C. 2009: HIV patients presenting common adverse drug events caused by highly active antiretroviral therapy in Tanzania Tanzania Journal of Health Research 11(1): 5-10
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157